2026.06.01
The Second Xiangya Hospital of Central S···
Led by Academician Han Yaling and co-chaired by Professors PanXiangbinandWang Yan, the clinical tria···
2026.05.26
3-Year Clinical Outcomes of HighLife TSM···
EuroPCR 2026, the European Congress onInterventional Cardiology, was grandly held in Paris, France f···
2026.04.10
First Patient Implant in the U.S. EFS fo···
In April, 2026, the first patient implant in the U.S. FDA Early Feasibility Study (“EFS”) for the Ge···
2026.03.18
FDA Approved Trilogy THV System, Peijia ···
On March 18, JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Hea···
2026.03.18
Focusing on New Advances in AR Treatment···
At EuroPCR 2026, transcatheter aortic regurgitation therapy stood out as a core structural heart dis···
2026.03.17
DCwire Micro Guidewire Received FDA 510(···
In March , 2026 , DCwire MicroGuide wire , independently designed and developed by Achieva Medical L···
2026.02.09
SUBMISSION OF EU MDR CE MARK REGISTRATIO···
The board (the “Board”) of directors (the “Directors”) of the Company is pleased toannounce that the···
2026.01.26
HighLife Secured CE Mark, Pioneering a N···
On January 26, 2026, HighLife SAS, an innovative French medical company, announced a significant mil···
2025.12.26
SmartWave Medical Wins "Excellence Award···
In December 2025, the finals of the 2025 National Unicorn EnterpriseCompetitionconcluded. SmartWave ···
2025.12.13
ReachTact TAVR Assistance SystembyZhiche···
In December 2025, the ReachTact TAVR Assistance System, independentlydeveloped by Zhicheng Medical T···
2025.12.12
Peijia Medical Received NMPA Approval fo···
Peijia Medical (9996.HK), a leading Chinese domestic company inthehigh-growthtranscatheter valve the···
2025.12.08
Regurgitation Application of TaurusNXTNo···
In December 2025, Peijia Medical announced that the Companyreceivedaconfirmation letter from NMPA co···
